Subclinical inflammation and obesity, diabetes and related disorders

Drug Discovery Today: Disease Mechanisms

Volumn 2, Issue 3, 2005, Pages 307-312

  Schmidt, Maria Inês ^a   Saad, Mário J A ^b   Duncan, Bruce B ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; AUTACOID; C REACTIVE PROTEIN; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 6; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN SERINE KINASE; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; CALORIC INTAKE; CELL SIZE; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIETARY INTAKE; DISEASE ASSOCIATION; EATING HABIT; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; MOLECULAR MECHANICS; NITROSATION; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PROTEIN MODIFICATION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 33645048989     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2005.08.003     Document Type: Review

References (54)

1. S. Wild et. al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047-1053
2. M.A. Lazar How obesity causes diabetes: Not a tall tale Science 307 2005 373-375
3. Duncan, B.B. et al. The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes. Diabetes Technol. Ther. (in press)
4. M.I. Schmidt et. al. Diabesity: An inflammatory metabolic condition Clin. Chem. Lab. Med. 41 2003 1120-1130
5. E. Lopez-Garcia et. al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction J. Nutr. 135 2005 562-566
6. S. Liu et. al. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women Am. J. Clin. Nutr. 75 2002 492-498
7. T.A. Mori et. al. Omega-3 fatty acids and inflammation Curr. Atheroscler. Rep. 6 2004 461-467
8. T. Goldberg et. al. Advanced glycoxidation end products in commonly consumed foods J. Am. Diet. Assoc. 104 2004 1287-1291
9. H. Vlassara et. al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy Proc. Natl. Acad. Sci. U.S.A. 99 2002 15596-15601
10. P. Dandona et. al. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation Circulation 111 2005 1448-1454
11. A. Ceriello et. al. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment Diabetes 53 2004 701-710
12. Y. Lin et. al. The hyperglycemia-induced inflammatory response in adipocytes: The role of reactive oxygen species J. Biol. Chem. 280 2005 4617-4626
13. T. Nishikawa et. al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787-790
14. B.B. Lowell et. al. Mitochondrial dysfunction and type 2 diabetes Science 307 2005 384-387
15. P.C. Schulze et. al. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein J. Biol. Chem. 279 2004 30369-30374
16. R.B. Singh et. al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high-risk patients (Indo-Mediterranean Diet Heart Study): A randomised single-blind trial Lancet 360 2002 1455-1461
17. K. Esposito et. al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial JAMA 292 2004 1440-1446
18. J.L. Chiasson et. al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial JAMA 290 2003 486-494
19. L. Fontana et. al. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans Proc. Natl. Acad. Sci. U.S.A. 101 2004 6659-6663
20. S.S. Bassuk et. al. Physical activity and the prevention of cardiovascular disease Curr. Atheroscler. Rep. 5 2003 299-307
21. A. Imhof et. al. Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: Results from three MONICA samples (Augsburg, Glasgow, Lille) Eur. Heart J. 25 2004 2092-2100
22. P. Cohen et. al. Leptin and the control of metabolism: Role for stearoyl-CoA desaturase-1 (SCD-1) J. Nutr. 134 2004 2455S-2463S
23. P. Dobrzyn et. al. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver Proc. Natl. Acad. Sci. U.S.A. 101 2004 6409-6414
24. T. Kakuma et. al. Role of leptin in peroxisome proliferator-activated receptor gamma coactivator-1 expression Endocrinology 141 2000 4576-4582
25. A.D. Attie et. al. PGC-1alpha at the crossroads of type 2 diabetes Nat. Genet. 34 2003 244-245
26. M. Shimabukuro et. al. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression Proc. Natl. Acad. Sci. U.S.A. 95 1998 9558-9561
27. M. Kubo et. al. Suppressors of cytokine signaling and immunity Nat. Immunol. 4 2003 1169-1176
28. H. Shi et. al. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling J. Biol. Chem. 279 2004 34733-34740
29. E. Ottaviani et. al. A new theory on the common evolutionary origin of natural immunity, inflammation and stress response: The invertebrate phagocytic immunocyte as an eye-witness Domest. Anim. Endocrinol. 15 1998 291-296
30. G.S. Hotamisligil Inflammatory pathways and insulin action Int. J. Obes. Relat. Metab. Disord. 27 Suppl. 3 2003 S53-S55
31. J. Auwerx PPARgamma, the ultimate thrifty gene Diabetologia 42 1999 1033-1049
32. M.W. Rajala et. al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting Diabetes 53 2004 1671-1679
33. L. Patel et. al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochem. Biophys. Res. Commun. 300 2003 472-476
34. S.P. Weisberg et. al. Obesity is associated with macrophage accumulation in adipose tissue J. Clin. Invest. 112 2003 1796-1808
35. B.B. Duncan et. al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study Diabetes 53 2004 2473-2478
36. Y. Matsuzawa Adipocytokines: Emerging therapeutic targets Curr. Atheroscler. Rep. 7 2005 58-62
37. L. Pirola et. al. Modulation of insulin action Diabetologia 47 2004 170-184
38. Y. Zick Role of Ser/Thr kinases in the uncoupling of insulin signaling Int. J. Obes. Relat. Metab. Disord. 27 Suppl. 3 2003 S56-S60
39. L. Pirola et. al. Modulators of insulin action and their role in insulin resistance Int. J. Obes. Relat. Metab. Disord. 27 Suppl. 3 2003 S61-S64
40. M. Yuan et. al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta Science 293 2001 1673-1677
41. J. Hirosumi et. al. A central role for JNK in obesity and insulin resistance Nature 420 2002 333-336
42. G.C. Barreiro et. al. Aspirin inhibits serine phosphorylation of IRS-1 in muscle and adipose tissue of septic rats Biochem. Biophys. Res. Commun. 320 2004 992-997
43. P.O. Prada et. al. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion Endocrinology 146 2005 1576-1587
44. M. Perreault et. al. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle Nat. Med. 7 2001 1138-1143
45. M.A. Carvalho-Filho et. al. S-Nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: A novel mechanism of insulin resistance Diabetes 54 2005 959-967
46. T. Yasukawa et. al. S-Nitrosylation-dependent inactivation of Akt/ protein kinase B in insulin resistance J. Biol. Chem. 280 2005 7511-7518
47. C.J. Rhodes Type 2 diabetes - a matter of beta-cell life and death? Science 307 2005 380-384
48. J.K. Howard et. al. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3 Nat. Med. 10 2004 734-738
49. U. Ozcan et. al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes Science 306 2004 457-461
50. M.A. Vincent et. al. Active role for the vasculature in the delivery of insulin to skeletal muscle Clin. Exp. Pharmacol. Physiol. 32 2005 302-307
51. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N. Engl. J. Med. 352 2005 1685-1695
52. M. Peppa et. al. The role of advanced glycation end products in the development of atherosclerosis Curr. Diab. Rep. 4 2004 31-36
53. P.C. Schulze et. al. Oxidative stress and atherosclerosis Curr. Atheroscler. Rep. 7 2005 242-248
54. A. Ceriello et. al. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arterioscler. Thromb. Vasc. Biol. 24 2004 816-823